logo

For the Inventor, By the Inventor

Tampa, FL, United States of America

Romark Laboratories L.c.


USPTO Granted Patents = 38

% Expired Patents = 36.8



Trademarks = 2

Forward Citations = 477

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Jean-Francois Rossignol (30 out of 36 patents)

silverMedal J Edward Semple (13 out of 13 patents)

bronzeMedal Marc S Ayers (7 out of 7 patents)

4.  Jean-Francedillaois Rossignol (5 out of 6 patents)

5.  Andrew Stachulski (3 out of 3 patents)

6.  Jean Francois Rossignol (3 out of 3 patents)

7.  Maria Gabriella Santoro (2 out of 2 patents)

8.  Marc Ayers (0 patent)

9.  Maria Gabriella Santoro (0 patent)


Core Competencies:
Influenza
Nitazoxanide
Thiazolide Compounds
Controlled Release
Viral Infections
Prodrugs
Cancer Treatment
Pharmaceutical Compositions
Antiviral Composition
Hepatitis Treatment
Haloalkyl Compounds
Equine Protozoal Treatment

38 patents:

1. 11850237 - Compounds and methods for treating influenza (2023-12-26),
2. 11426388 - Controlled release pharmaceutical formulations of nitazoxanide (2022-08-30),
3. 11173149 - Inhibition of protein disulfide-isomerase A3 (2021-11-16),
4. 11135202 - Thiazolide compounds for treating viral infections (2021-10-05),
5. 10912768 - Compounds and methods for treating influenza (2021-02-09),
6. 10814612 - Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections (2020-10-27),
7. 10577337 - Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof (2020-03-03),
8. RE47786 - Haloalkyl heteroaryl benzamide compounds (2019-12-30),
9. 10383855 - Controlled release pharmaceutical formulations of nitozoxanide (2019-08-20),
10. 10363243 - Compounds and methods for treating influenza (2019-07-30),
11. 10358428 - Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof (2019-07-23),
12. 10336058 - Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections (2019-07-02),
13. RE47404 - Viral hepatitis treatment (2019-05-27),
14. 10100023 - Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof (2018-10-16),
15. RE46724 - Haloalkyl heteroaryl benzamide compounds (2018-02-19),
Company Overview
Romark Laboratories L.C. is a biopharmaceutical company based in Tampa, Florida, specializing in the development of innovative therapies for infectious diseases and cancer. The organization focuses on harnessing advanced research methodologies to create novel treatments, particularly in the areas of antiviral and anticancer agents. With a commitment to improving patient outcomes, Romark is dedicated to addressing unmet medical needs through its cutting-edge research and development initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

38 Patents

#17 in Tampa, FL

#208 in Florida

#9,027 in US

#17,844 in the World

Tampa, FL (US)
Tampa, FL, United States of America

Romark Laboratories L.c.

Forward Citations = 477

7 inventors:

goldMedal Jean-Francois Rossignol (30 out of 36 patents)

silverMedal J Edward Semple (13 out of 13 patents)

bronzeMedal Marc S Ayers (7 out of 7 patents)

4.  Jean-Francedillaois Rossignol (5 out of 6 patents)

5.  Andrew Stachulski (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Romark Laboratories L.c.. Retrieved from https://idiyas.com/company/romark-laboratories-l-c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…